BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 20737573)

  • 1. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.
    Glehen O; Gilly FN; Boutitie F; Bereder JM; Quenet F; Sideris L; Mansvelt B; Lorimier G; Msika S; Elias D;
    Cancer; 2010 Dec; 116(24):5608-18. PubMed ID: 20737573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL
    Am J Surg; 2011 Feb; 201(2):149-56. PubMed ID: 20832051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
    Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
    Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis.
    Capone A; Valle M; Proietti F; Federici O; Garofalo A; Petrosillo N
    J Surg Oncol; 2007 Nov; 96(6):507-13. PubMed ID: 17708508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
    Klaver YL; Chua TC; de Hingh IH; Morris DL
    J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives?
    Sugarbaker PH
    Am J Surg; 2011 Feb; 201(2):157-9. PubMed ID: 20870209
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
    Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
    J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
    Yan TD; Zappa L; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
    J Surg Oncol; 2007 Aug; 96(2):102-12. PubMed ID: 17221852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed...
    Lambert LA; Mansfield PF
    Ann Surg Oncol; 2007 Nov; 14(11):3037-9. PubMed ID: 17726635
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].
    Iesalnieks I; Kullmann F; Dahlke M; Ghali N; Agha A; von Breitenbuch P; Schoelmerich J; Schlitt HJ; Piso P
    Z Gastroenterol; 2006 Dec; 44(12):1237-45. PubMed ID: 17163375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.
    Glehen O; Gilly FN; Arvieux C; Cotte E; Boutitie F; Mansvelt B; Bereder JM; Lorimier G; Quenet F; Elias D;
    Ann Surg Oncol; 2010 Sep; 17(9):2370-7. PubMed ID: 20336386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
    Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
    Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments.
    Roviello F; Caruso S; Marrelli D; Pedrazzani C; Neri A; De Stefano A; Pinto E
    Surg Oncol; 2011 Mar; 20(1):e38-54. PubMed ID: 20888755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends.
    Maggiori L; Elias D
    Eur J Surg Oncol; 2010 Jul; 36(7):599-603. PubMed ID: 20605396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.